Manning Paul B 13D and 13G filings for Verrica Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-26 4:15 pm Purchase |
2024-11-22 | 13D | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 52,504,049 49.900% |
37,114,568 (+241.17%) |
Filing |
| 2022-07-15 4:15 pm Purchase |
2022-07-05 | 13D | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 15,389,481 37.400% |
4,761,904 (+44.81%) |
Filing |
| 2022-02-14 4:37 pm Purchase |
2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 10,627,577 38.600% |
789,830 (+8.03%) |
Filing |
| 2021-02-16 4:04 pm Purchase |
2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Manning Paul B | 9,837,747 38.000% |
194,500 (+2.02%) |
Filing |